Calendar Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Delayed Nasdaq 01:07:17 2024-03-28 pm EDT 5-day change 1st Jan Change
0.32 USD -3.09% Intraday chart for Galmed Pharmaceuticals Ltd. +1.20% -29.67%

Chart calendar Galmed Pharmaceuticals Ltd.

6ad64c5e069694cbb205042.dhyzLklP4mYnANQ5AamEw1Ada8v-2MmFTIxQ7zd9skY.KWyKeB0FkiNiZZxSefny9RpbLfinrZ_wKOUqgHgLwTMgS_RCcAeAMEl5vw~bb925be91eae4380ae8f7230355eeb2c

Upcoming events on Galmed Pharmaceuticals Ltd.

2024-05-07 Q1 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Galmed Pharmaceuticals Ltd.

2024-03-13 Q4 2023 Earnings Release (Projected)
2023-06-20 09:00 am Maxim Group Virtual Healthcare Conference
2023-06-01 08:00 am Q1 2023 Earnings Release
2023-05-04 10:00 am Annual General Meeting
2022-08-04 08:00 am Interim 2022 Earnings Release
2022-05-17 08:00 am Q1 2022 Earnings Release
2022-05-02 08:30 am FY 2021 Earnings Call
2022-05-02 07:00 am FY 2021 Earnings Release
2021-11-11 AASLD The Liver Meeting
2021-11-08 08:30 am Q3 2021 Earnings Call - ARMOR Phase 3 Study Update
2021-11-08 07:30 am Q3 2021 Earnings Release
2021-08-05 08:30 am Interim 2021 Earnings Call
2021-08-05 07:00 am Interim 2021 Earnings Release
2021-05-13 08:30 am Q1 2021 Earnings Call
2021-05-13 07:50 am Q1 2021 Earnings Release
2021-03-18 08:30 am FY 2020 Earnings Call
2021-03-18 07:00 am FY 2020 Earnings Release
2020-11-18 08:00 am Stifel Healthcare Conference
2020-11-12 08:30 am Q3 2020 Earnings Call
2020-11-12 07:00 am Q3 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
2,04
2,17
-5.91%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-20,1
-20,0
-0.55%
-28,1
-23,3
-20.62%
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-10,7
-9,46
-13.22%
-22,4
-21,6
-3.78%
-30,2
-27,7
-9.15%
-32,9
-34,2
3.75%
-17,7
-18,9
6.43%

-8,20

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,78
-9,00
-8.68%
-20,5
-19,8
-3.27%
-28,8
-26,2
-9.61%
-32,5
-33,6
3.28%
-17,9
-18,9
5.32%

-7,75

Net income
Million USD
Released
Forecast
Spread
-9,86
-8,94
-10.26%
-20,5
-19,8
-3.27%
-28,8
-26,2
-9.61%
-32,5
-33,5
3.11%
-17,9
-18,9
5.32%

-7,75

EPS
USD
Released
Forecast
Spread
-8,10
-7,41
-9.37%
-14,5
-14,1
-3.47%
-20,2
-18,6
-9.05%
-19,8
-19,8
0.15%
-10,6
-11,2
5.33%

-2,63

Announcement Date13/03/1912/03/2018/03/2102/05/2229/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-7,83
-6,80
-15.21%



























EBIT
Million USD
Released
Forecast
Spread
-7,85
-9,18
14.53%
-7,49
-8,95
16.3%
-6,09
-8,27
26.36%
-3,73
-6,56
43.11%
-5,38
-4,19
-28.32%
-2,45
-3,66
33.11%
-2,00
-2,50
19.86%
-1,87
-2,04
8.37%
-1,47
-1,97
25.6%

-2,35

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,71
-9,08
15.01%
-7,45
-8,55
12.83%
-6,14
-8,25
25.56%
-3,37
-6,54
48.39%
-5,35
-4,16
-28.54%
-2,64
-3,64
27.54%
-1,83
-2,50
26.74%
-1,59
-2,04
21.99%
-1,47
-1,97
25.34%

-2,35

Net income
Million USD
Released
Forecast
Spread
-7,71
-9,08
15.01%
-7,45
-8,55
12.83%
-6,14
-8,25
25.56%
-3,37
-6,54
48.39%
-5,35
-4,16
-28.54%
-2,64
-3,64
27.54%
-1,83
-2,50
26.74%
-1,59
-2,04
21.99%
-1,47
-1,97
25.34%

-2,35

EPS
USD
Released
Forecast
Spread
-4,65
-5,37
13.41%
-4,50
-4,54
0.83%
-3,60
-4,80
25%
-2,25
-3,54
36.44%
-3,15
-2,48
-27.27%
-1,50
-2,10
28.57%
-1,09
-1,50
27.33%
-0,95
-0,34
-179.41%
-0,24
-0,27
11.11%

-0,32

Announcement Date08/11/2102/05/2217/05/2204/08/2216/11/2229/03/2301/06/2309/08/2322/11/23-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise